China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China flag China · Delayed Price · Currency is CNY
17.47
-0.38 (-2.13%)
May 12, 2026, 3:04 PM CST

SHE:300294 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8,80911,39615,26916,98318,43519,338
Market Cap Growth
-41.14%-25.36%-10.10%-7.88%-4.67%35.36%
Enterprise Value
6,0098,28910,03511,91913,97817,731
Last Close Price
17.4722.6029.9132.8035.4136.96
PE Ratio
2564.48101.1238.4671.5242.6656.13
Forward PE
26.2719.5626.0029.0030.9532.40
PS Ratio
4.785.538.806.406.687.30
PB Ratio
1.181.532.042.322.532.79
P/TBV Ratio
1.391.802.552.432.973.23
P/FCF Ratio
--149.7130.6440.2515.14
P/OCF Ratio
-186.3250.9326.4730.9114.37
EV/Sales Ratio
3.264.035.784.495.076.69
EV/EBITDA Ratio
19.2219.9319.2319.0923.2834.72
EV/EBIT Ratio
39.0230.3723.7722.5227.5642.78
EV/FCF Ratio
-9.58-98.4021.5130.5213.88
Debt / Equity Ratio
0.010.010.000.000.010.01
Debt / EBITDA Ratio
0.240.160.020.040.060.07
Debt / FCF Ratio
--0.120.040.080.03
Net Debt / Equity Ratio
-0.37-0.42-0.47-0.72-0.64-0.61
Net Debt / EBITDA Ratio
-9.11-7.61-6.68-8.49-7.81-8.32
Net Debt / FCF Ratio
4.476.68-34.18-9.56-10.24-3.33
Asset Turnover
0.220.240.210.330.350.42
Inventory Turnover
0.961.050.792.061.871.74
Quick Ratio
4.874.065.4012.857.657.83
Current Ratio
6.325.066.7414.088.618.95
Return on Equity (ROE)
0.04%1.51%5.36%3.40%6.27%6.45%
Return on Assets (ROA)
1.14%2.00%3.25%4.17%4.05%4.05%
Return on Invested Capital (ROIC)
3.45%6.60%11.64%16.09%16.13%10.41%
Return on Capital Employed (ROCE)
2.00%3.60%5.50%7.20%6.90%5.90%
Earnings Yield
0.04%0.99%2.60%1.40%2.34%1.78%
FCF Yield
-7.12%-4.16%0.67%3.26%2.48%6.60%
Dividend Yield
1.25%0.99%1.07%0.92%0.56%0.41%
Payout Ratio
4561.28%138.77%58.54%42.47%19.25%13.36%
Buyback Yield / Dilution
-2.65%-1.94%0.54%-0.53%-15.24%-2.30%
Total Shareholder Return
-1.40%-0.95%1.61%0.38%-14.67%-1.89%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.